Cancer Cell Metabolism, Glycolysis, Lactate Production and Transport and Potential Therapeutic Options for Inhibitors
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (1 November 2022) | Viewed by 5062
Special Issue Editor
Special Issue Information
Dear Colleague,
Glucose conversion to lactate in cancer cells is a hallmark of accelerated glucose consumption and growth rate as described almost a century ago by Otto Warburg. More recently, research has identified that increased glycolysis in cancer cells leads to enhanced cellular lactate and increased lactate export to the tumor microenvironment, resulting in a lower pH. Increased cellular lactate accumulation has been shown to increase oncogene expression, leading to reprogramming of cellular metabolism toward glycolysis as opposed to mitochondrial oxidative phosphorylation, known as the “lactogenesis hypothesis”. Potential drugs focused on blunting glycolysis in cancer cells may reduce cellular growth rates, increase sensitivity to anticancer drugs, and provide an additional tool to oncologists in their therapy arsenal.
Prof. Dr. Christopher J. Rivard
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glycolysis
- lactate production
- lactate dehydrogenase
- metabolomics
- cancer cell biology
- Warburg effect
- LDH inhibitors
- cellular lactate transporters
- tumor microenvironment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.